CBR recently processed and stored the newborn stem cells from the cord blood of its 300,000th client. This is a milestone that’s important not just because of its sheer size, but, more importantly, because of what it means for CBR’s leadership role in advancing regenerative medicine.
A population of 300,000 people is equivalent...